CLEC12A and acute myeloid leukemia: Furthermore, this finding was not restricted to high risk MDS or MDS with excess blasts, as could be surmised from the established fact of CLEC12A as a marker of blasts and LSCs in AML, suggesting a role for this marker in the broad spectrum of myelodysplastic disorders.